These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 17086009)

  • 1. Cost-effectiveness of impedance cardiography testing in uncontrolled hypertension.
    Ferrario CM; Smith RD;
    Am Heart Hosp J; 2006; 4(4):279-89. PubMed ID: 17086009
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cost-effectiveness of self-management of blood pressure in hypertensive patients over 70 years with suboptimal control and established cardiovascular disease or additional cardiovascular risk diseases (TASMIN-SR).
    Penaloza-Ramos MC; Jowett S; Mant J; Schwartz C; Bray EP; Sayeed Haque M; Richard Hobbs FD; Little P; Bryan S; Williams B; McManus RJ
    Eur J Prev Cardiol; 2016 Jun; 23(9):902-12. PubMed ID: 26603745
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Telemonitoring and self-management in the control of hypertension (TASMINH2): a cost-effectiveness analysis.
    Kaambwa B; Bryan S; Jowett S; Mant J; Bray EP; Hobbs FD; Holder R; Jones MI; Little P; Williams B; McManus RJ
    Eur J Prev Cardiol; 2014 Dec; 21(12):1517-30. PubMed ID: 23990660
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effectiveness of an impedance cardiography guided treatment strategy to improve blood pressure control in a real-world setting: results from a pragmatic clinical trial.
    Lu Y; Wang L; Wang H; Gu J; Ma ZJ; Lian Z; Zhang Z; Krumholz H; Sun N
    Open Heart; 2021 Sep; 8(2):. PubMed ID: 34580169
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The effect of hemodynamically-guided hypotensive therapy in one-year observation: Randomized, prospective and controlled trial (FINEPATH study).
    Krzesiński P; Gielerak G; Stańczyk A; Piotrowicz K; Uziębło-Życzkowska B; Banak M; Kurpaska M; Michalczyk Ł; Jurek A; Wolszczak K; Galas A; Wójcik A; Skrobowski A
    Cardiol J; 2016; 23(2):132-40. PubMed ID: 26876066
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Value of noninvasive hemodynamics to achieve blood pressure control in hypertensive subjects.
    Smith RD; Levy P; Ferrario CM;
    Hypertension; 2006 Apr; 47(4):771-7. PubMed ID: 16520405
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparative Cost-Effectiveness of Conservative or Intensive Blood Pressure Treatment Guidelines in Adults Aged 35-74 Years: The Cardiovascular Disease Policy Model.
    Moise N; Huang C; Rodgers A; Kohli-Lynch CN; Tzong KY; Coxson PG; Bibbins-Domingo K; Goldman L; Moran AE
    Hypertension; 2016 Jul; 68(1):88-96. PubMed ID: 27181996
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Individualizing hypertension treatment with impedance cardiography: a meta-analysis of published trials.
    Ferrario CM; Flack JM; Strobeck JE; Smits G; Peters C
    Ther Adv Cardiovasc Dis; 2010 Feb; 4(1):5-16. PubMed ID: 20042450
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cost effectiveness analysis of improved blood pressure control in hypertensive patients with type 2 diabetes: UKPDS 40. UK Prospective Diabetes Study Group.
    UK Prospective Diabetes Study Group
    BMJ; 1998 Sep; 317(7160):720-6. PubMed ID: 9732339
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Use of Impedance Cardiography to Guide Blood Pressure Lowering Medication Selection: Systematic Review of Randomized Controlled Trials.
    Viera AJ; Hart L; Gomez Altamirano P; Tuttle B; Price A; Sherwood A
    Am J Hypertens; 2024 Oct; 37(11):916-923. PubMed ID: 38990869
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cost effectiveness of losartan in patients with hypertension and LVH: an economic evaluation for Sweden of the LIFE trial.
    Jönsson B; Carides GW; Burke TA; Dasbach EJ; Lindholm LH; Dahlöf B;
    J Hypertens; 2005 Jul; 23(7):1425-31. PubMed ID: 15942467
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cost effectiveness of intensive treatment of hypertension. Based on presentations by Donald S. Shepard, PhD; and Dominic Hodgkin, PhD.
    Am J Manag Care; 1998 Dec; 4(12 Suppl):S765-9; discussion S770. PubMed ID: 10339108
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The influence of absolute cardiovascular risk, patient utilities, and costs on the decision to treat hypertension: a Markov decision analysis.
    Montgomery AA; Fahey T; Ben-Shlomo Y; Harding J
    J Hypertens; 2003 Sep; 21(9):1753-9. PubMed ID: 12923409
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Improvement in blood pressure control with impedance cardiography-guided pharmacologic decision making.
    Sharman DL; Gomes CP; Rutherford JP
    Congest Heart Fail; 2004; 10(1):54-8. PubMed ID: 14872160
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cost-Effectiveness of Screening for Primary Aldosteronism and Subtype Diagnosis in the Resistant Hypertensive Patients.
    Lubitz CC; Economopoulos KP; Sy S; Johanson C; Kunzel HE; Reincke M; Gazelle GS; Weinstein MC; Gaziano TA
    Circ Cardiovasc Qual Outcomes; 2015 Nov; 8(6):621-30. PubMed ID: 26555126
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cost-effectiveness and clinical effectiveness of catheter-based renal denervation for resistant hypertension.
    Geisler BP; Egan BM; Cohen JT; Garner AM; Akehurst RL; Esler MD; Pietzsch JB
    J Am Coll Cardiol; 2012 Oct; 60(14):1271-7. PubMed ID: 22981547
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cost-effectiveness of Intensive Blood Pressure Management.
    Richman IB; Fairley M; Jørgensen ME; Schuler A; Owens DK; Goldhaber-Fiebert JD
    JAMA Cardiol; 2016 Nov; 1(8):872-879. PubMed ID: 27627731
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cost-effectiveness of treating resistant hypertension with an implantable carotid body stimulator.
    Young KC; Teeters JC; Benesch CG; Bisognano JD; Illig KA
    J Clin Hypertens (Greenwich); 2009 Oct; 11(10):555-63. PubMed ID: 19817936
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The cost effectiveness of hypertension treatment in Sweden.
    Johannesson M
    Pharmacoeconomics; 1995 Mar; 7(3):242-50. PubMed ID: 10155314
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cost-effectiveness evaluation of a home blood pressure monitoring program.
    Billups SJ; Moore LR; Olson KL; Magid DJ
    Am J Manag Care; 2014 Sep; 20(9):e380-7. PubMed ID: 25364874
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.